Adaptin Bio, Inc.
APTN
$6.20
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -90.03% | -59.66% | -51.28% | -85.77% | -77.70% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -100.00% | -100.00% | -100.00% | 101.12% |
| Total Other Non-Cash Items | 207.94% | -12.91% | 5,062.90% | 10,316.67% | -320,100.00% |
| Change in Net Operating Assets | 114.49% | -25.80% | 5.83% | -57.93% | -732.79% |
| Cash from Operations | 73.85% | -723.69% | -64.90% | -401.82% | -2,441.69% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 66.40% | -- | -- | -- | -- |
| Issuance of Common Stock | -89.42% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 90.43% | -115.06% | 100.00% | -- | -- |
| Cash from Financing | -90.51% | 400.67% | -100.00% | -100.00% | 5,033.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -106.75% | -47.66% | -944.15% | -5,568.98% | 779,933.33% |